“Producing predictably differentiated, characterized and functional cells for large-scale allogeneic iPSC treatments requires the kind of development and production sensitivity that comes only from ...

One of the many challenges in cell therapy manufacturing is the thoughtful deployment of capital and technology in the set-up of a manufacturing facility, which is dependent on factors that can differ ...